Brought to you by 
Provista licenses biomarker technology from Arizona State University
06 Nov 2013
Executive Summary
Arizona State University's Biodesign Institute licensed molecular diagnostics firm Provista Diagnostics Inc. rights to biomarker technologies pertaining to the early detection of breast cancer, ovarian cancer, and human papilloma virus (HPV). The deal was handled through ASU's Arizona Technology Enterprises tech transfer unit.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Provista licenses biomarker technology from Arizona State University
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice